These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3976024)

  • 1. [A new view on Hodgkin's disease. A review of the literature].
    Borum K
    Ugeskr Laeger; 1985 Jan; 147(4):250-3. PubMed ID: 3976024
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cellular immunity in Hodgkin's disease in complete remission].
    Burchardt K
    Pol Tyg Lek; 1980 Dec; 35(50):1937-40. PubMed ID: 7291045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cellular immunity and clinico-histological stage in Hodgkin's disease].
    Fabris C; De Sanctis C; Ciriotti G; Ponzone A
    Minerva Pediatr; 1971 Feb; 23(5):190-3. PubMed ID: 5574421
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
    Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE
    Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vivo studies, using the skin-window technic, on the inflammatory cellular reactivity in hodgkin's disease].
    Maglulo E; Carcò FP; Giraldi M; Sprovieri G
    Arch De Vecchi Anat Patol; 1967 Dec; 50(3):615-27. PubMed ID: 4951032
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased "active" rosette-forming cells during remission in Hodgkin's disease.
    Lang JM; Bigel P; Oberling F; Mayer S
    Biomedicine; 1978 May; 29(3):83-4. PubMed ID: 687748
    [No Abstract]   [Full Text] [Related]  

  • 7. Responses to tests of cell mediated immunity before, during and after BCG administration in Hodgkin's disease.
    Lenzini L; Bracci R; Rottoli P; Rottoli L
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:300. PubMed ID: 4546904
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppressive effect of adherent mononuclear cells from peripheral blood of patients with Hodgkin's disease on PHA responsiveness.
    Moghe MV; Advani SH; Gangal SG
    Indian J Exp Biol; 1981 Dec; 19(12):1101-6. PubMed ID: 7333645
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current immunologic data on Hodgkin's disease].
    Weisgerber C; Kourilsky FM
    Rev Prat; 1974 Oct; 24(45):3927-9. PubMed ID: 4445766
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor antigens in Hodgkin's lymphogranuloma].
    Antonaci S; Tribalto M; Mandelli F; Dammacco F
    Recenti Prog Med; 1976 Aug; 61(2):211-8. PubMed ID: 1037142
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes of the cellular immunity tests during the evolution of Hodgkin's disease.
    Răileanu-Moţoiu I; Dumitrescu A; Costescu M; Mocanu N; Berceanu S
    Med Interne; 1983; 21(3):203-15. PubMed ID: 6665494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological aspects of Hodgkin's disease.
    Baldwin RW
    Proc R Soc Med; 1972 Dec; 65(12):1113. PubMed ID: 4346774
    [No Abstract]   [Full Text] [Related]  

  • 13. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
    Hersh EM
    Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte response to pokeweed mitogen in Hodgkin's disease.
    Cohnen G; König E; Augener W; Brittinger G
    Biomedicine; 1973 Jun; 19(6):239-43. PubMed ID: 4752298
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunology in Hodgkin's disease.
    Gollerkeri MP
    Indian J Cancer; 1972 Dec; 9(4):312-5. PubMed ID: 4144182
    [No Abstract]   [Full Text] [Related]  

  • 16. International symposium on Hodgkin's disease. Session 2. Histopathology and experimental cytology. Invited discussion: Synthesis and implications for the etiology, pathogenesis and spread of Hodgkin's disease.
    Berard CW
    Natl Cancer Inst Monogr; 1973 May; 36():261-3. PubMed ID: 4355349
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of levamisole in Hodgkin's disease.
    Berényi E; Sonkoly I; Kávai M; Szabolcsi M; Szegedi G
    N Engl J Med; 1977 Apr; 296(16):941. PubMed ID: 846517
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various current theories on the immunopathogenesis of Hodgkin's disease].
    Płusa T
    Pol Tyg Lek; 1981 Jan; 36(3):113-5. PubMed ID: 6454127
    [No Abstract]   [Full Text] [Related]  

  • 20. Zoster and Hodgkin's disease.
    Br Med J; 1972 Jul; 3(5819):130-1. PubMed ID: 5039773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.